Review
Published on 21 Mar 2023
Precision diagnostics in chronic lymphocytic leukemia: Past, present and future
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1146486
- 6,968 views
- 14 citations
Type at least 3 characters
1,276 articles
Original Research
Published on 17 Mar 2023
CLL stereotyped B-cell receptor immunoglobulin sequences are recurrent in the B-cell repertoire of healthy individuals: Apparent lack of central and early peripheral tolerance censoring
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1112879
- 4,417 views
- 5 citations
Review
Published on 17 Mar 2023
SF3B1 mutations in myelodysplastic syndromes: A potential therapeutic target for modulating the entire disease process
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1116438
- 19,785 views
- 16 citations
Case Report
Published on 16 Mar 2023
Pathological fracture due to primary bone lymphoma in a patient with a history of prostate cancer: A case report and review of literature
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1100559
- 3,243 views
- 1 citation
Original Research
Published on 16 Mar 2023
Long-term outcomes of third-line therapy with tyrosine kinase inhibitors in chronic phase chronic myeloid leukemia: A real-life experience
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1138683
- 2,492 views
Review
Published on 15 Mar 2023
New insights into hepatitis B virus lymphotropism: Implications for HBV-related lymphomagenesis
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1143258
- 3,360 views
- 2 citations
Brief Research Report
Published on 15 Mar 2023
Real-world experience of sorafenib maintenance after allogeneic hematopoietic stem cell transplantation for FLT3-ITD AML reveals high rates of toxicity-related treatment interruption
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1095870
- 3,372 views
- 11 citations
Case Report
Published on 15 Mar 2023
Case report: Invasive fungal infection in a patient with a rare CVID-causing gene (TNFRSF13B) mutation undergoing AML treatment
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1017230
- 2,351 views
Case Report
Published on 14 Mar 2023
Case report: Germline RECQL mutation potentially involved in hereditary predisposition to acute leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1066083
- 1,828 views
- 2 citations
Review
Published on 14 Mar 2023
Research Topic: Measurable Residual Disease in Hematologic Malignancies. Can digital droplet PCR improve measurable residual disease monitoring in chronic lymphoid malignancies?
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1152467
- 3,248 views
- 1 citation
Original Research
Published on 14 Mar 2023
NTRK fusion protein expression is absent in a large cohort of diffuse large B-cell lymphoma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1146029
- 1,643 views
- 1 citation
Original Research
Published on 10 Mar 2023
Clinical and genomic characterization of Chinese patients with functional high-risk multiple myeloma: A real-world validation study
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1110693
- 3,702 views
- 5 citations
Brief Research Report
Published on 10 Mar 2023
Comparison of first-line treatment with bendamustine plus rituximab versus R-CHOP for patients with follicular lymphoma grade 3A: Results of a retrospective study from the Fondazione Italiana Linfomi
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1120967
- 4,880 views
- 5 citations
Review
Published on 10 Mar 2023
LSD1 inhibition modulates transcription factor networks in myeloid malignancies
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1149754
- 6,571 views
- 7 citations
Editorial
Published on 09 Mar 2023
Editorial: Advances in the treatment of chronic myeloid leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1166588
- 2,787 views
- 2 citations
Original Research
Published on 09 Mar 2023
A novel conditioning regimen of chidamide, cladribine, gemcitabine, and busulfan in the autologous stem cell transplantation of aggressive T-cell lymphoma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1143556
- 2,044 views
- 1 citation